Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIa trial of Hepalatide for chronic hepatitis D
CTR20232208Phase 2Completed
- Sponsor
- Shanghai Hepu Pharmaceutical
- Start
- Oct 2023
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of hepalatide in Chronic Viral Hepatitis B With Delta-Agent, sponsored by Shanghai Hepu Pharmaceutical. Started Oct 2023; status: completed.
02
Drugs
hepalatide
03
Conditions
Chronic Viral Hepatitis B With Delta-Agent
Beyond the preview
Go deeper on CTR20232208.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20232208.